Why is genomics now unfashionable in drug discovery?

Add to your list(s) Download to your calendar using vCal

• Quin Wills (SimuGen)
• Wednesday 13 October 2010, 14:00-15:00
• MR4, Centre for Mathematical Sciences, Wilberforce Road, Cambridge.

If you have a question about this talk, please contact Danielle Stretch.

The pharmaceutical industry is experiencing a significant innovation crisis. It would seem that the era of ‘big hit’ drugs, science driven by high-throughput chemistry and pharmaceutical companies is nearing an end, with most major drug patents expiring within two years. Only just a few years ago there was enormous excitement around how functional genomics and other ‘high resolution’ technologies would allow systems biology to reinvigorate drug R&D. These days we see a large return to traditional methods, amidst complaints that omics hasn’t truly helped make any decisions but just added to the data burden.

The talk will be a general discussion on current drug discovery trends, ‘big data’ approaches, ‘open-source’ biology, where the problems are, and suggested solutions. As a case study, we will use toxicogenomics software and models developed in-house at SimuGen, a pharmacogenomics company born at CCBI .

This talk is part of the Computational and Systems Biology series.

This talk is included in these lists:

• All CMS Events
• All Talks (aka the CURE list)
• Biology
• CamBridgeSens
• Cambridge talks
• Computational and Systems Biology
• Graduate-Seminars
• Life Science Interface Seminars
• Life Sciences
• Life Sciences
• ME Seminar
• MR4, Centre for Mathematical Sciences, Wilberforce Road, Cambridge
• PMRFPS's
• School of Physical Sciences
• Trust & Technology Initiative - interesting events
• custom
• my_list
• other talks
• se393's list

Note that ex-directory lists are not shown.